FDA Opens the Door for People with Asthma to Use Antifungal Therapy Pulmazole
Asthma, Cystic Fibrosis, News
The U.S. Food and Drug Administration has agreed to Pulmatrix’s request to consider making the lung-fungus therapy Pulmazole (PUR1900) available to people with asthma in addition to people with allergic bronchopulmonary aspergillosis, or ... Read more